InspireMD Inc reports results for the quarter ended in January - Earnings Summary

InspireMD

14/05/2024 14:31

* InspireMD Inc  NSPR.OQ  reported a quarterly adjusted loss
of 21
cents​​ per share for the quarter ended in January, higher than
the same quarter last year, when the company reported EPS of -53
cents.  The lone analyst forecast for the quarter was for a loss
of 15 cents per share. 
    * Revenue rose 22% to $1.51 million from a year ago;
analysts
expected $1.38 million. 
    * InspireMD Inc's reported EPS for the quarter was a loss
of 21
cents​.
    * The company reported a quarterly loss of $7.03 million.
    * InspireMD Inc shares had risen by 1.3% this quarter and
lost 14.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 11.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for InspireMD Inc is
$4.50 
This summary was machine generated from LSEG data May 14 at
01:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.15          -0.21          Missed
 Dec. 31 2023      -0.19          -0.16          Beat
 Sep. 30 2023      -0.15          -0.15          Met
 Jun. 30 2023      -0.30          -0.24          Beat